DavidMitchellSmithMDFACP, FIDSA(He/Him)
[Pronunciation: Davey]
Infectious Disease • San Diego, CAHIV/AIDS Medicine
Asst Vice Chancellor of Clinical and Translational Research Professor of Medicine, UCSD School of Medicine
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 619-543-8080
Summary
- Dr. David (Davey) Smith is an infectious disease specialist in La Jolla, CA and is affiliated with UC San Diego and VA San Diego Healthcare System. He received his medical degree from East Tennessee State University James H. Quillen College of Medicine and has been in practice for over 25 years. He specializes in HIV/AIDS and COVID medicine and is experienced in virology.
Education & Training
University of California (San Diego) Medical CenterFellowship, Infectious Disease, 2000 - 2003- University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 1999 - 2000
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1996 - 1999
East Tennessee State University James H. Quillen College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1997 - 2025
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Member American Society of Clinical Investigation, 2015
- Fellow American College of Physicians, 2014
- HIV Medical Association Researcher of the Year IDSA
- Join now to see all
Publications & Presentations
PubMed
- Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.Kara W Chew, Brooke McGinley, Carlee Moser, Jonathan Z Li, Teresa H Evering
The Journal of Infectious Diseases. 2025-02-04 - Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug-Drug Interactions Between Immunosuppressants and Cannabis-Derived Products.Matthew R Allen, Gwenyth Portillo Wightman, Zechariah Zhu, Adam Poliak, Davey M Smith
Drug Safety. 2025-01-01 - Quality of Life in People With HIV at the End of Life: Preliminary Results From the Last Gift Observational Cohort Study.Brahm Coler, Gordon Honerkamp Smith, Anish K Arora, Adam Wells, Stephanie Solso
Journal of Acquired Immune Deficiency Syndromes. 2025-01-01
Press Mentions
What’s Behind Wild State-by-State Variations in Long COVID?December 17th, 2024- How Much Does Long COVID Cost Society? New Data Shed LightOctober 21st, 2024
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
